OIG Advisory Opinion 25-11: Key Compliance Insights for Manufacturers

In Advisory Opinion 25-11 issued December 15, 2025, the Department of Health and Human Services Office of Inspector General (OIG) offers important and practical guidance for pharmaceutical and medical device manufacturers on its approach to evaluating discount and rebate arrangements under the Federal Anti-Kickback Statute (AKS).... By: Gardner Law